It looks like WuXi will be the manufacturer of efti as it appears they have exclusive rights ,if I recall reading correctly,I think Immutep is to receive monies from any efti sold for any trials of efti
Under the partnership, WuXi Biologics will be Prima’s exclusive clinical manufacturer worldwide for IMP321, a protein developed by Prima for use in oncology .
IMM Chart, page-13
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.8¢ | 31.5¢ | $454.9K | 1.415M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2870 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 474352 | 6 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
